12. Berliner Lymphologisches Symposium
„Ödeme in verschiedenen Lebensphasen“ lautete das Leitthema des 12. Berliner Lymphologischen Symposiums am 22.04.2023. U…
„Ödeme in verschiedenen Lebensphasen“ lautete das Leitthema des 12. Berliner Lymphologischen Symposiums am 22.04.2023. U…
PARAVAN GmbH together with its UK partner Precision Rehab will present the versatile and individually adaptable PR serie…
Lightweight multifunctional power wheelchairs with standing, lying, sitting and tilting functions fill a gap in the chil…
Die lange Nacht der Lymphologie 2022 Vom 25. bis 26. November 2022 fand zum 3. Mal das „Wiener Lymphologische Sympos…
. Collaboration with Fraunhofer IZI further expanded Funding provided by Sächsische Aufbaubank BellaSeno GmbH, an I…
Xenikos B.V., focused on the development of innovative immunotherapies for the treatment of patients suffering from seri…
Icon Genetics GmbH (ICON) successfully completed a Phase I clinical study on the safety and immunogenicity of personaliz…
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoim…
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indic…
AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for it…